BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19967282)

  • 1. [Available resources for the treatment of breast cancer in Mexico].
    Mohar A; Bargalló E; Ramírez MT; Lara F; Beltrán-Ortega A
    Salud Publica Mex; 2009; 51 Suppl 2():s263-9. PubMed ID: 19967282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Descriptive epidemiology cancer in the National Cancer Institute of Mexico].
    Mohar A; Frías-Mendivil M; Suchil-Bernal L; Mora-Macías T; de la Garza JG
    Salud Publica Mex; 1997; 39(4):253-8. PubMed ID: 9381247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of malignant breast lesions in Mexico].
    López-Carrillo L; Torres-Sánchez L; López-Cervantes M; Rueda-Neria C
    Salud Publica Mex; 2001; 43(3):199-202. PubMed ID: 11452695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of gastric lymphoma at 6 hospitals in Mexico City].
    Arista J; Jiménez F; Noble A; Lazos M; Cuesta T; Cortés E; Herrera R
    Rev Gastroenterol Mex; 2001; 66(2):96-100. PubMed ID: 11917443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
    Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
    J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico.
    Bright K; Barghash M; Donach M; de la Barrera MG; Schneider RJ; Formenti SC
    Breast; 2011 Apr; 20 Suppl 2():S54-9. PubMed ID: 21371885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
    Oestreicher N; Ramsey SD; McCune JS; Linden HM; Veenstra DL
    Cancer; 2005 Nov; 104(10):2054-62. PubMed ID: 16216002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic outcomes of breast cancer survivorship: CALGB study 79804.
    Hensley ML; Dowell J; Herndon JE; Winer E; Stark N; Weeks JC; Paskett E
    Breast Cancer Res Treat; 2005 May; 91(2):153-61. PubMed ID: 15868443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
    Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
    Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry.
    Phillips KA; Milne RL; Buys S; Friedlander ML; Ward JH; McCredie MR; Giles GG; Hopper JL
    J Clin Oncol; 2005 Jul; 23(21):4679-86. PubMed ID: 15851764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waiting time for breast cancer surgery in Quebec.
    Mayo NE; Scott SC; Shen N; Hanley J; Goldberg MS; MacDonald N
    CMAJ; 2001 Apr; 164(8):1133-8. PubMed ID: 11338798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a surveillance programme for women with a family history of breast cancer.
    Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
    J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to make the best use of limited resources in breast cancer treatment--experiences in Bosnia & Herzegovina.
    Obralić N; Beslija S
    J BUON; 2006; 11(1):21-9. PubMed ID: 17318948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer in Mexico. Is it a young women disease?].
    Rodríguez-Cuevas S; Macías Martínez CG; Labastida Almendaro S
    Ginecol Obstet Mex; 2000 May; 68():185-90. PubMed ID: 10902285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment.
    Mandelblatt JS; Lawrence WF; Cullen J; Stanton AL; Krupnick JL; Kwan L; Ganz PA
    J Clin Oncol; 2006 Jan; 24(1):77-84. PubMed ID: 16382116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in Mexico: a pressing priority.
    Knaul FM; Nigenda G; Lozano R; Arreola-Ornelas H; Langer A; Frenk J
    Reprod Health Matters; 2008 Nov; 16(32):113-23. PubMed ID: 19027629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community.
    Oluwole SF; Ali AO; Adu A; Blane BP; Barlow B; Oropeza R; Freeman HP
    J Am Coll Surg; 2003 Feb; 196(2):180-8. PubMed ID: 12595043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
    Choi WS; Parker BA; Pierce JP; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):317-20. PubMed ID: 8722225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of clinical and pathological features of breast cancer in women with 40 years old and younger vs 70 years old and older].
    Cuan Martínez JR; Mainero Ratchelous FE; Aguilar Gallegos IU; Bernechea Miranda A; Buenrostro Pineda MA; Burgos Portillo I; Cortés Herrera AE; Burguete Vera JJ
    Ginecol Obstet Mex; 2008 Jun; 76(6):299-306. PubMed ID: 18800585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of breast self-examination (BSE) program for detection early stage of breast cancer.
    Kamproh S; Fungpong S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S147-51. PubMed ID: 19253511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.